Company: 

FRAILomic

FRAILomic

Project responsibilities included:

Definition of objectives and audience

  • Objectives: Clarify goals, such as raising awareness, influencing policy, or promoting collaboration
  • Audience: Identify target groups like fellow researchers, industry partners, policymakers and the general public

Development of core messaging

  • Summarise the research program’s purpose, findings and implications in clear, engaging language
  • Tailor messages to resonate with different audience segments

Selection of communication channels

  • Academic Channels: Publish in peer-reviewed journals, present at conferences and share on academic platforms like ResearchGate or Academia.edu
  • Digital Media: Use social media (Twitter, LinkedIn), blogs and program-specific websites to share updates and engage audiences
  • Traditional Media: Distribute press releases, articles and op-eds in newspapers or magazines
  • Public Outreach: Host webinars, workshops, or community events

Content creation

  • Written: Summaries, white papers, policy briefs, or infographics for easy comprehension
  • Visual: Develop explainer videos, slide decks and graphics
  • Interactive: Create webinars, podcasts, or Q&A sessions to encourage engagement

Collaboration with stakeholders

  • Partner with universities, funding bodies and advocacy organisations for broader reach
  • Engage influencers in relevant fields for amplification

Monitor, adapt and legacy

  • Use analytics to track engagement across channels
  • Adjust strategies based on feedback and performance metrics
  • Develop a repository for the program’s outputs, such as a dedicated website or data portal, to ensure accessibility and longevity
What our client said

"Niche team were identified as the partners for delivering the communication platform, building our strategic communications plan and coordinating our dissemination and exploitation activities. Together, we generated and promoted a host of scientific and tertiary communications detailing our initiatives and findings."

photophotophotophotophoto

Professor Leocadio Rodriguez Mañas

Hospital Universitario de Getafe (Madrid)




Request copy of the testimonial
Project background
The FRAILOMIC initiative was an international research project aimed at improving the understanding, diagnosis and management of frailty in older populations. Frailty, a condition characterized by increased vulnerability to stressors and reduced ability to perform daily activities, is a significant predictor of adverse outcomes such as hospitalisation, disability and mortality. The prevalence of frailty increases with age, making its early detection and management crucial in mitigating its progression to disability and associated healthcare burdens. FRAILOMIC focused on identifying biomarkers—both clinical and laboratory-based—that could predict the risk of frailty, enhance its diagnostic accuracy and assess its prognosis. These biomarkers were expected to improve the clinical management of frailty by enabling earlier interventions and better prediction of outcomes such as disability and loss of independence. The initiative was supported by a consortium of 20 institutions across nine countries, including universities, research centers and hospitals (and Niche). Key collaborators included institutions from Spain, the UK and other European nations. The project involved analyzing biomarkers from approximately 75,000 older individuals using advanced “omics” technologies, with samples drawn from diverse cohorts. The initiative consisted of two phases: an exploratory phase to identify potential biomarkers and a validation phase to test their effectiveness in predicting, diagnosing and monitoring frailty. Ultimately, FRAILOMIC aimed to develop user-friendly clinical tools for healthcare providers to address frailty proactively, improving the quality of life for aging populations and reducing the healthcare burden associated with disability.
Delivery

NST worked with FRAILOMIC to create an omnichannel dissemination package for an academic research program. This involved designing a coordinated communication strategy that leverages multiple platforms and media to share research findings effectively with diverse audiences. The goal is to ensure that the research impacts stakeholders such as academics, policymakers, practitioners and the public.

Related Case studies

Adaptimmune

Medical writing

QC review of an IB update for uzatresgene autoleucel, one of Adaptimmune’s TCR-based therapies.

Niche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping.

read more

British Society for Haematology

Medical writing

BSH is the UK’s largest haematology organisation, promoting excellence within the field and supporting professional development.

Over a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards.

read more

Synairgen plc

Medical writing

A specialist respiratory biotech company whose primary focus is developing our investigative inhaled IFN-β for the treatment of severe viral lung infections.

At the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta.

read more

Recardio Inc

Medical writing

Recardio Inc is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of cardiovascular diseases.

From Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory.

read more

Cleothena Enterprises Pty Ltd

Medical writing

Cleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic solutions.

When stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche —.

read more

ViiV Healthcare

Medical writing

A specialist pharmaceutical company dedicated to HIV medicines and research with an extensive portfolio of prescription medicines.

Putting patients first, Niche supported ViiV Healthcare's global HIV outreach programmes with medical writing,.

read more

Astex Pharmaceuticals

Medical writing

Specialising in the discovery and development of small-molecule drugs for oncology and central nervous system disorders.

Niche provided Astex with expert regulatory writing across their oncology pipeline, delivering clinical protocols, study.

read more

Nabriva Therapeutics

Medical writing

Nabriva Therapeutics is committed to developing new antibiotics to treat infectious diseases.

Niche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada.

read more

Assign DMB

Medical writing

Partnership with a clinical research organisation specialising in comprehensive data services for clinical trials.

For over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical.

read more

BioKinetic Europe

Medical writing

A clinical research organisation specialising in early-phase clinical trials focusing on pharmacokinetic, pharmacodynamic and first-in-human studies.

A trusted writing partner to this Belfast-based early-phase CRO for over a decade, Niche turned BioKinetic Europe's.

read more

Scandinavian Development Services

Medical writing

Providing regulatory and medical writing support to meet client needs

Niche served as the English-language regulatory writing backbone for this Nordic consultancy, producing IBs, IMPDs and.

read more

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility